New Delhi, Aug 8 (IBNS): Ozone Pharmaceuticals, India’s leading prescription drug manufacturing and marketing company, has introduced “Uniform Pricing Strategy” where medicines for several chronic diseases will now be made available by the company just for Rs. 2 per day, across the dosage strengths of medicines.
This is an endeavour to help patients suffering from High Blood Pressure, High Cholesterol and High Blood Sugar.
This ‘Uniform Pricing’ strategy ensures lifelong affordable cost of therapy to withstand a lifelong compliance to medicines.
Today household expenditure on drugs constitutes more than 50 per cent of all out-of-pocket spending on health. Reducing this burden requires a carefully crafted plan, Uniform Pricing Strategy (UPS) is a first ever initiative by Ozone Pharmaceuticals assuring affordable access to drugs that can make a big difference.
“Considering the rising prices of products and services in India, Ozone is pleased to introduce a practical solution that contributes to a healthy India. We take pride in being the first pharmaceutical company to introduce such a strategy,” says S.C Sehgal, Chairman, Ozone Pharmaceuticals.
“India is very soon going to be world’s capital for chronic diseases such as Hypertension, High Blood Pressure, High Cholesterol and Diabetes. Medicines to manage these diseases are to be taken for life to secure lifelong happiness," says A.K Sahoo, CEO, Ozone Pharmaceuticals.
"In such instances, the highly expensive costing of potent medicines can prevent their optimal dose as per the doctor’s prescription. Through its uniform pricing policy, Ozone Pharmaceuticals perseveres to ascertain an affordable lifelong compliance to medicines,” says Sahoo.
